Cargando…

Combining targeted biological agents with radiotherapy : current status and future directions /

Radiotherapy plays an integral role in cancer treatment. Approximately 60% of cancer patients will receive radiotherapy at some point in their treatment. A major improvement in patient outcomes occurs with the use of combined chemotherapy and radiotherapy. The combination of targeted biological agen...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Small, William, Jr
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York : Demos Medical Pub., ©2008.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 EBSCO_ocn248476905
003 OCoLC
005 20231017213018.0
006 m o d
007 cr cnu---unuuu
008 080912s2008 nyua ob 001 0 eng d
040 |a N$T  |b eng  |e pn  |c N$T  |d OCLCQ  |d IDEBK  |d OCLCQ  |d TUU  |d OCLCQ  |d CDX  |d E7B  |d TMY  |d RTH  |d OCLCQ  |d OCLCF  |d NLGGC  |d YDXCP  |d OCLCA  |d EBLCP  |d MERUC  |d AU@  |d OCLCQ  |d D6H  |d AGLDB  |d OCLCO  |d JBG  |d OCLCO  |d TOA  |d OCLCO  |d PIFAG  |d OCLCQ  |d WY@  |d OCLCO  |d OCLCA  |d LUE  |d OCLCO  |d GILDS  |d OCLCO  |d VNS  |d VTS  |d TOF  |d OCLCO  |d OCLCA  |d STF  |d OCLCO  |d M8D  |d OCLCO  |d UKAHL  |d OCLCQ  |d OCLCA  |d INARC  |d OCLCO  |d OCLCQ  |d ANO  |d OCLCQ 
016 7 |a 101463557  |2 DNLM 
019 |a 316005845  |a 429902503  |a 437219691  |a 476175462  |a 492160518  |a 646761857  |a 781382444  |a 992022930  |a 1285467705 
020 |a 9781935281009  |q (electronic bk.) 
020 |a 1935281003  |q (electronic bk.) 
020 |a 9781933864341 
020 |a 1933864346 
024 8 |a 2862913 
029 1 |a AU@  |b 000044822526 
029 1 |a AU@  |b 000051356385 
029 1 |a CDX  |b 9673700 
029 1 |a DEBBG  |b BV043095627 
029 1 |a DEBSZ  |b 422089389 
029 1 |a GBVCP  |b 802649858 
035 |a (OCoLC)248476905  |z (OCoLC)316005845  |z (OCoLC)429902503  |z (OCoLC)437219691  |z (OCoLC)476175462  |z (OCoLC)492160518  |z (OCoLC)646761857  |z (OCoLC)781382444  |z (OCoLC)992022930  |z (OCoLC)1285467705 
037 |a 1933864346  |b Rittenhouse  |n http://www/r2library.com 
050 4 |a RC271.R3  |b C66 2008eb 
060 4 |a 2008 J-234 
060 4 |a QZ 266  |b C7315 2008 
072 7 |a MED  |x 062000  |2 bisacsh 
072 7 |a HEA  |x 039030  |2 bisacsh 
082 0 4 |a 616.99/40642  |2 22 
049 |a UAMI 
245 0 0 |a Combining targeted biological agents with radiotherapy :  |b current status and future directions /  |c edited by William Small, Jr. 
260 |a New York :  |b Demos Medical Pub.,  |c ©2008. 
300 |a 1 online resource (xiv, 226 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references and index. 
505 0 |a Targeted therapies: definitions, limitations, and future directions / Tamara Z .Vern and William Small Jr. -- Epidermal growth factor receptors (EGFR) / Michael P. Hagan [and others] -- Vascular epithelial growth factor (VEGF) receptors / Andrew N. Fontanella, Yiting Cao, and Mark W. Dewhirst. 
505 0 |a Dermatologic manifestations of targeted therapies / Mario E. Lacouture, Bharat B. Mittal, and Mark Agulnik -- Radiolabeled monoclonal antibody therapies / Lanea M.M. Keller [and others] -- Targeted therapies in malignant gliomas / Sean Grimm -- Targeted therapies in head and neck cancer / Ranee Mehra, Roger B. Cohen, and Paul M. Harari. 
505 0 |a Targeted therapies in lung cancer / Gregory M.M. Videtic -- Targeted therapies in pancreatic cancer / Sunil Krishnan, Vishal Rana, and Christopher H. Crane -- Targeted therapies in cervical cancer / Christopher J. Anker and David K. Gaffney -- Targeted therapies in endometrial cancer / Jergin Chen and David K. Gaffney. 
588 0 |a Print version record. 
520 |a Radiotherapy plays an integral role in cancer treatment. Approximately 60% of cancer patients will receive radiotherapy at some point in their treatment. A major improvement in patient outcomes occurs with the use of combined chemotherapy and radiotherapy. The combination of targeted biological agents with radiotherapy is the latest cutting-edge extension in cancer therapy for radiation oncologists. Combining Targeted Biological Agents with Radiotherapy: Current Status and Future Directions is an overview of the current state of clinical and pre-clinical research in combining radiotherapy w. 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
650 0 |a Cancer  |x Radiotherapy. 
650 0 |a Combined modality therapy. 
650 0 |a Growth factors  |x Receptors. 
650 1 2 |a Neoplasms  |x therapy 
650 2 |a Radiation Oncology 
650 2 |a Combined Modality Therapy 
650 2 2 |a Antineoplastic Agents  |x therapeutic use 
650 2 2 |a Radiotherapy  |x methods 
650 6 |a Cancer  |x Radiothérapie. 
650 6 |a Traitement combiné (Thérapeutique) 
650 6 |a Facteurs de croissance  |x Récepteurs. 
650 7 |a MEDICAL  |x Oncology.  |2 bisacsh 
650 7 |a HEALTH & FITNESS  |x Diseases  |x Cancer.  |2 bisacsh 
650 7 |a Cancer  |x Radiotherapy.  |2 fast  |0 (OCoLC)fst00845473 
650 7 |a Combined modality therapy.  |2 fast  |0 (OCoLC)fst00868995 
650 7 |a Growth factors  |x Receptors.  |2 fast  |0 (OCoLC)fst00948612 
700 1 |a Small, William,  |c Jr. 
776 0 8 |i Print version:  |t Combining targeted biological agents with radiotherapy.  |d New York : Demos Medical Pub., ©2008  |z 9781933864341  |z 1933864346  |w (DLC) 2008001694  |w (OCoLC)190867404 
856 4 0 |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=237613  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH32080316 
938 |a Coutts Information Services  |b COUT  |n 9673700 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL353758 
938 |a EBSCOhost  |b EBSC  |n 237613 
938 |a Internet Archive  |b INAR  |n combiningtargete0000unse 
938 |a YBP Library Services  |b YANK  |n 2862913 
994 |a 92  |b IZTAP